2015
DOI: 10.1016/j.amjcard.2015.04.026
|View full text |Cite
|
Sign up to set email alerts
|

Review of Eligibility for Cardiac Resynchronization Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 53 publications
0
5
0
Order By: Relevance
“…1,2 Among unselected patients hospitalized with HF, the proportion meeting these historic criteria was relatively consistent, ranging from 6% to 10%. [3][4][5][6][7] Subsequent landmark clinical trials demonstrated similar benefits from CRT in patients with milder symptoms (NYHA Class I/II). 8,9 Evidence is also accruing of efficacy in patients with atrial fibrillation (AF) and milder left ventricular systolic dysfunction (LVSD) meeting criteria for pacing due to bradycardia.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations
“…1,2 Among unselected patients hospitalized with HF, the proportion meeting these historic criteria was relatively consistent, ranging from 6% to 10%. [3][4][5][6][7] Subsequent landmark clinical trials demonstrated similar benefits from CRT in patients with milder symptoms (NYHA Class I/II). 8,9 Evidence is also accruing of efficacy in patients with atrial fibrillation (AF) and milder left ventricular systolic dysfunction (LVSD) meeting criteria for pacing due to bradycardia.…”
Section: Introductionmentioning
confidence: 99%
“…A minor concomitant contraction in eligibility has occurred, with guidelines now favouring LBBB morphology in patients with moderate QRS prolongation. As outlined in a recent systematic review, no study to date has examined the proportion of patients fulfilling these new criteria …”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…CRT improves cardiac function, symptoms, quality of life and exercise capacity and reduces HF hospitalizations, ventricular arrhythmias, and mortality and is cost-effective (6)(7)(8)(9)(10). Although up to 14% of patients with HF meet the eligibility criteria for CRT, it appears generally underused, with great heterogeneity in its implementation in North America and Europe and elsewhere (11)(12)(13).…”
Section: Introductionmentioning
confidence: 99%